Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Sep;96(3):1328–1335. doi: 10.1172/JCI118168

Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells.

M S Jacewicz 1, D W Acheson 1, M Mobassaleh 1, A Donohue-Rolfe 1, K A Balasubramanian 1, G T Keusch 1
PMCID: PMC185755  PMID: 7657808

Abstract

Differentiated villus intestinal epithelial cells express globotriaosylceramide, the Shiga-like toxin 1 (SLT-1) receptor, and are sensitive to toxin-mediated cytotoxicity, whereas undifferentiated crypt cells neither express Gb3 nor respond to toxin. To investigate if SLT-1 receptors are maturationally regulated in human intestinal cells, we examined the effect of butyrate, a known transcriptional regulator of differentiation genes in many cell types, using cultured colonic cancer-derived epithelial cell lines. Exposure to butyrate increased villus cell marker enzymes such as alkaline phosphatase, sucrase, and lactase, expression of toxin receptors, and sensitivity to SLT-1 in villus-like CaCo-2A and HT-29 cells. These effects were reversibly inhibited by preincubation of CaCo-2A cells with actinomycin D or cycloheximide. Butyrate-treated CaCo-2A cells unable to bind fluoresceinated SLT-1 B subunit were undifferentiated as assessed by alkaline phosphatase activity. HT-29 cells induced to differentiate by another signal, glucose deprivation, upregulated receptor content and response to toxin. Crypt-like T-84 cells responded to butyrate with a modest increase in alkaline phosphatase and toxin binding, but no induction of sucrase or lactase, and no change in sensitivity to toxin. The results demonstrate that expression of SLT-1 toxin receptors and toxin sensitivity are coregulated with cellular differentiation in cultured intestinal cells.

Full text

PDF
1328

Images in this article

1329Image
on p.1329
1330Image
on p.1330
1330Image
on p.1330
1333Image
on p.1333
1333Image
on p.1333
1333Image
on p.1333
1333Image
on p.1333
1333Image
on p.1333
1333Image
on p.1333

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acheson D. W., Calderwood S. B., Boyko S. A., Lincicome L. L., Kane A. V., Donohue-Rolfe A., Keusch G. T. Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems. Infect Immun. 1993 Mar;61(3):1098–1104. doi: 10.1128/iai.61.3.1098-1104.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Agarwal V. P., Schimmel E. M. Diversion colitis: a nutritional deficiency syndrome? Nutr Rev. 1989 Sep;47(9):257–261. doi: 10.1111/j.1753-4887.1989.tb02857.x. [DOI] [PubMed] [Google Scholar]
  3. Augeron C., Laboisse C. L. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res. 1984 Sep;44(9):3961–3969. [PubMed] [Google Scholar]
  4. Boerner P., Saier M. H., Jr Effects of 5-azacytidine, sodium butyrate, and phorbol esters on amino acid transport system A in a kidney epithelial cell line, MDCK: evidence for multiple mechanisms of regulation. J Cell Physiol. 1988 Oct;137(1):117–124. doi: 10.1002/jcp.1041370114. [DOI] [PubMed] [Google Scholar]
  5. Boffa L. C., Vidali G., Mann R. S., Allfrey V. G. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J Biol Chem. 1978 May 25;253(10):3364–3366. [PubMed] [Google Scholar]
  6. Chung Y. S., Song I. S., Erickson R. H., Sleisenger M. H., Kim Y. S. Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in human colorectal cancer cell lines. Cancer Res. 1985 Jul;45(7):2976–2982. [PubMed] [Google Scholar]
  7. Cummings J. H., Pomare E. W., Branch W. J., Naylor C. P., Macfarlane G. T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987 Oct;28(10):1221–1227. doi: 10.1136/gut.28.10.1221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. DeGrandis S., Law H., Brunton J., Gyles C., Lingwood C. A. Globotetraosylceramide is recognized by the pig edema disease toxin. J Biol Chem. 1989 Jul 25;264(21):12520–12525. [PubMed] [Google Scholar]
  9. Dexter D. L., Konieczny S. F., Lawrence J. B., Shaffer M., Mitchell P., Coleman J. R. Induction by butyrate of differentiated properties in cloned murine rhabdomyosarcoma cells. Differentiation. 1981;18(2):115–122. doi: 10.1111/j.1432-0436.1981.tb01111.x. [DOI] [PubMed] [Google Scholar]
  10. Dharmsathaphorn K., McRoberts J. A., Mandel K. G., Tisdale L. D., Masui H. A human colonic tumor cell line that maintains vectorial electrolyte transport. Am J Physiol. 1984 Feb;246(2 Pt 1):G204–G208. doi: 10.1152/ajpgi.1984.246.2.G204. [DOI] [PubMed] [Google Scholar]
  11. Donohue-Rolfe A., Acheson D. W., Kane A. V., Keusch G. T. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies. Infect Immun. 1989 Dec;57(12):3888–3893. doi: 10.1128/iai.57.12.3888-3893.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Donohue-Rolfe A., Keusch G. T., Edson C., Thorley-Lawson D., Jacewicz M. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. J Exp Med. 1984 Dec 1;160(6):1767–1781. doi: 10.1084/jem.160.6.1767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem. 1988 Jan 15;171(1-2):45–50. doi: 10.1111/j.1432-1033.1988.tb13756.x. [DOI] [PubMed] [Google Scholar]
  14. Gabius S., Yamazaki N., Hanewacker W., Gabius H. J. Regulation of distribution, amount and ligand affinity of sugar receptors in human colon carcinoma cells by treatment with sodium butyrate, retinoic acid and phorbol ester. Anticancer Res. 1990 Jul-Aug;10(4):1005–1012. [PubMed] [Google Scholar]
  15. Henneberry R. C., Fishman P. H. Morphological and biochemical differentiation in HeLa cells. Effects of cycloheximide on butyrate-induced process formation and ganglioside metabolism. Exp Cell Res. 1976 Nov;103(1):55–62. doi: 10.1016/0014-4827(76)90240-8. [DOI] [PubMed] [Google Scholar]
  16. Jacewicz M. S., Mobassaleh M., Gross S. K., Balasubramanian K. A., Daniel P. F., Raghavan S., McCluer R. H., Keusch G. T. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. J Infect Dis. 1994 Mar;169(3):538–546. doi: 10.1093/infdis/169.3.538. [DOI] [PubMed] [Google Scholar]
  17. Jacewicz M., Clausen H., Nudelman E., Donohue-Rolfe A., Keusch G. T. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med. 1986 Jun 1;163(6):1391–1404. doi: 10.1084/jem.163.6.1391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jacewicz M., Feldman H. A., Donohue-Rolfe A., Balasubramanian K. A., Keusch G. T. Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells. J Infect Dis. 1989 May;159(5):881–889. doi: 10.1093/infdis/159.5.881. [DOI] [PubMed] [Google Scholar]
  19. Kandel G., Donohue-Rolfe A., Donowitz M., Keusch G. T. Pathogenesis of Shigella diarrhea. XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport. J Clin Invest. 1989 Nov;84(5):1509–1517. doi: 10.1172/JCI114327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Leder A., Leder P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell. 1975 Jul;5(3):319–322. doi: 10.1016/0092-8674(75)90107-5. [DOI] [PubMed] [Google Scholar]
  21. Lindberg A. A., Brown J. E., Strömberg N., Westling-Ryd M., Schultz J. E., Karlsson K. A. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem. 1987 Feb 5;262(4):1779–1785. [PubMed] [Google Scholar]
  22. Matsumoto H., Erickson R. H., Gum J. R., Yoshioka M., Gum E., Kim Y. S. Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell line Caco-2. Gastroenterology. 1990 May;98(5 Pt 1):1199–1207. doi: 10.1016/0016-5085(90)90334-w. [DOI] [PubMed] [Google Scholar]
  23. McCafferty D. M., Zeitlin I. J. Short chain fatty acid-induced colitis in mice. Int J Tissue React. 1989;11(4):165–168. [PubMed] [Google Scholar]
  24. Messer M., Dahlqvist A. A one-step ultramicro method for the assay of intestinal disaccharidases. Anal Biochem. 1966 Mar;14(3):376–392. doi: 10.1016/0003-2697(66)90280-6. [DOI] [PubMed] [Google Scholar]
  25. Mobassaleh M., Donohue-Rolfe A., Jacewicz M., Grand R. J., Keusch G. T. Pathogenesis of shigella diarrhea: evidence for a developmentally regulated glycolipid receptor for shigella toxin involved in the fluid secretory response of rabbit small intestine. J Infect Dis. 1988 May;157(5):1023–1031. doi: 10.1093/infdis/157.5.1023. [DOI] [PubMed] [Google Scholar]
  26. Mobassaleh M., Gross S. K., McCluer R. H., Donohue-Rolfe A., Keusch G. T. Quantitation of the rabbit intestinal glycolipid receptor for Shiga toxin. Further evidence for the developmental regulation of globotriaosylceramide in microvillus membranes. Gastroenterology. 1989 Aug;97(2):384–391. doi: 10.1016/0016-5085(89)90074-7. [DOI] [PubMed] [Google Scholar]
  27. Mobassaleh M., Koul O., Mishra K., McCluer R. H., Keusch G. T. Developmentally regulated Gb3 galactosyltransferase and alpha-galactosidase determine Shiga toxin receptors in intestine. Am J Physiol. 1994 Oct;267(4 Pt 1):G618–G624. doi: 10.1152/ajpgi.1994.267.4.G618. [DOI] [PubMed] [Google Scholar]
  28. Nathan D. F., Burkhart S. R., Morin M. J. Increased cell surface EGF receptor expression during the butyrate-induced differentiation of human HCT-116 colon tumor cell clones. Exp Cell Res. 1990 Sep;190(1):76–84. doi: 10.1016/0014-4827(90)90146-2. [DOI] [PubMed] [Google Scholar]
  29. O'Brien A. D., Holmes R. K. Shiga and Shiga-like toxins. Microbiol Rev. 1987 Jun;51(2):206–220. doi: 10.1128/mr.51.2.206-220.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Parker M. I., de Haan J. B., Gevers W. DNA hypermethylation in sodium butyrate-treated WI-38 fibroblasts. J Biol Chem. 1986 Feb 25;261(6):2786–2790. [PubMed] [Google Scholar]
  31. Sandvig K., Prydz K., Ryd M., van Deurs B. Endocytosis and intracellular transport of the glycolipid-binding ligand Shiga toxin in polarized MDCK cells. J Cell Biol. 1991 May;113(3):553–562. doi: 10.1083/jcb.113.3.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sandvig K., Ryd M., Garred O., Schweda E., Holm P. K., van Deurs B. Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. J Cell Biol. 1994 Jul;126(1):53–64. doi: 10.1083/jcb.126.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut. 1994 Jan;35(1 Suppl):S35–S38. doi: 10.1136/gut.35.1_suppl.s35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Scheppach W., Sommer H., Kirchner T., Paganelli G. M., Bartram P., Christl S., Richter F., Dusel G., Kasper H. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 1992 Jul;103(1):51–56. doi: 10.1016/0016-5085(92)91094-k. [DOI] [PubMed] [Google Scholar]
  35. Schmidt H., Montag M., Bockemühl J., Heesemann J., Karch H. Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples. Infect Immun. 1993 Feb;61(2):534–543. doi: 10.1128/iai.61.2.534-543.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Toscani A., Soprano D. R., Soprano K. J. Sodium butyrate in combination with insulin or dexamethasone can terminally differentiate actively proliferating Swiss 3T3 cells into adipocytes. J Biol Chem. 1990 Apr 5;265(10):5722–5730. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES